Edema
📧 Sign up to get email alerts when something new happens for Edema.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-09-28FDA Approved: BUMEX — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for Bumex (bumetanide) filed by Validus Pharmaceuticals LLC.
-
FDA approval · 2015-09-16FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for HYDROCHLOROTHIAZIDE from Actavis Pharma, Inc., indicating an approved change to the product labe…
-
FDA approval · 2015-08-07FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for furosemide submitted by Chartwell RX, LLC.
-
FDA approval · 2015-06-05FDA Approved: FUROSEMIDE — Supplemental Application (Marlex Pharmaceuticals, Inc.)
FDA approved a supplemental NDA for furosemide from Marlex Pharmaceuticals, Inc., updating the product label.
-
FDA approval · 2015-04-26FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Spironolactone from Mylan Pharmaceuticals Inc., indicating an approved change to an already-appr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-04-15Clinical Trial Update: Does NMES Help Relieve Lower Limb Oedema and Improve Joint Mobility and Skin Tissue Oxygenation Levels? [NA]
This clinical trial update investigates whether neuromuscular electrical stimulation (NMES) can relieve lower limb edema, improve joint mobi…
-
FDA label_change · 2015-03-30FDA Approved: EDECRIN — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for EDECRIN (ethacrynic acid) submitted by Bausch Health US, LLC, updating the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Topical Treatment of Under Eye Dark Circles and Swelling [Phase 2]
A Phase 2 clinical trial evaluating a topical treatment for under-eye edema (dark circles and swelling) has completed, with results posted i…
-
FDA approval · 2014-12-19FDA Approved: ACETAZOLAMIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original application for acetazolamide from Heritage Pharmaceuticals (Avet) as a generic drug product.
-
FDA approval · 2014-10-22FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a generic spironolactone and hydrochlorothiazide combination product from Prasco Laboratories.
-
FDA approval · 2014-09-24FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for a generic spironolactone and hydrochlorothiazide combination product from Sun Pharmaceutical Ind…
-
FDA approval · 2014-08-26FDA Approved: FUROSEMIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved Heritage Pharmaceuticals' generic furosemide (ANDA 203428) for edema-related indications and hypertension, enabling a generic v…
-
FDA approval · 2014-07-23FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved the original application for Hydrochlorothiazide (ScieGen Pharmaceuticals, Inc.), a generic diuretic. It is indicated for hyper…
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients. [Phase 2]
Phase 2 trial evaluating the efficacy and safety of hypertonic saline in cardiac surgery patients has completed, with results posted.
-
FDA approval · 2014-04-23FDA Approved: SPIRONOLACTONE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original ANDA for spironolactone, authorizing a generic version manufactured by Jubilant Cadista Pharmaceuticals Inc.
-
FDA approval · 2014-03-06FDA Approved: SPIRONOLACTONE — Original Application (NorthStar Rx LLC)
The FDA approved NorthStar Rx LLC's Original Application for spironolactone (generic spironolactone).
-
FDA approval · 2014-01-27FDA Approved: FUROSEMIDE — Original Application (Civica, Inc.)
FDA approves Civica, Inc.’s original application for furosemide (generic diuretic).
-
FDA approval · 2014-01-22FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Hydrochlorothiazide submitted by Aurobindo Pharma Limited under an Abbreviated New Drug Applicat…
-
FDA approval · 2014-01-17FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the Spironolactone and Hydrochlorothiazide combination product (Prasco Laboratories), indica…
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure) [Phase 2]
A Phase 2 dose-finding study evaluated OPC-41061 for treating edema associated with congestive heart failure; the trial completed and result…
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions) [Phase 1]
Phase 1 trial update indicating completion of a study that uses magnetic marker monitoring for a furosemide-containing gastroretentive formu…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers [Phase 1]
Phase 1 dose-escalation trial of Xerecept given intravenously in Japanese and Caucasian volunteers to evaluate safety and dosing in edema.
-
FDA approval · 2013-06-12FDA Approved: ALDACTONE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Aldactone (spironolactone) from Pfizer. The approval updates the drug’s labeling.
-
FDA label_change · 2013-02-05FDA Approved: INDAPAMIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for indapamide from Actavis Pharma, resulting in labeling changes for the product.
-
FDA approval · 2013-02-05FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide from Mylan Pharmaceuticals Inc. (ANDA 086513).